Can familial combined hyperlipidemia diagnostic criteria be improved by the use of nomogram?

Nature Clinical Practice Cardiovascular Medicine

Volumn 1, Issue 2, 2004, Pages 78-79

  Thomas, Randal J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Apolipoprotein B; Familial combined hyperlipidemia; Total cholesterol; Triglyceride

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FAMILIAL COMBINED HYPERLIPIDEMIA; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SCORING SYSTEM; SHORT SURVEY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

EID: 20444487316     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0037     Document Type: Short Survey

References (3)

1. Hopkins PN et al. (2003) Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 108: 519-523
2. Hense HW et al. (2003) Framingham risk function overestimates risk of coronary heart disease in men and women from Germany - results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 24: 937-945
3. Assman G et al. (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) Study. Circulation 105: 310-315